New autism treatment trial seeks to ease social challenges
NCT ID NCT07303907
Summary
This study is testing a single dose of an investigational medicine called MM402 in about 20 adults with autism spectrum disorder (ASD). The main goal is to see if the medicine can help improve difficulties with socializing and communication. Researchers will measure how participants feel and how the medicine behaves in their bodies over 24 hours.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Spectrum Neuroscience and Treatment Institute
RECRUITINGNew York, New York, 10021, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.